Source comparison
Tesamorelin + Ipamorelin: Dosing Comparison
Before initiating any protocol, understanding how individual peptide doses translate into combined regimens helps calibrate research designs. The table below compares standalone Tesamorelin dosing, standalone Ipamorelin dosing, and the most commonly researched
This comparison does not assign a generated winner or score.
- Before initiating any protocol, understanding how individual peptide doses translate into combined regimens helps calibrate research designs. The table below compares standalone Tesamorelin dosing, standalone Ipamorelin dosing, and the most commonly researched combination protocols based on published clinical and preclinical data.
- Tesamorelin Monotherapy
- 2 mg daily
- None
- Once daily (evening)
- Visceral adipose reduction, HIV-associated lipodystrophy studies
- Well-studied with robust Phase III data; limited GH pulse amplitude compared to combination protocols
- Ipamorelin Monotherapy
- 200–300 mcg per dose
- 1–3 times daily
- GH pulsatility studies, lean mass preservation research
- Highly selective with minimal cortisol/prolactin elevation; lower total GH output than GHRH analogues alone
- Tesamorelin + Ipamorelin Standard Blend
- 1–2 mg daily
- 200–300 mcg daily
- Once daily (evening, combined injection)
- Body composition, metabolic marker studies, GH kinetics research
- Synergistic GH pulse amplitude (3–5× baseline); preserves pulsatility; most data supports once-daily evening dosing
- Tesamorelin + Ipamorelin Multi-Dose
- Tesamorelin once daily; Ipamorelin 2–3× daily
- Protocols requiring sustained GH elevation across waking hours
- Increases total daily GH exposure; limited evidence of added benefit over once-daily for body composition endpoints
- The combination protocol leverages dual-pathway activation. Tesamorelin's GHRH receptor binding primes pituitary responsiveness, while Ipamorelin's ghrelin mimicry amplifies the pulse without extending it. Research consistently shows the greatest synergy with once-daily evening administration aligned to circadian GH rhythms.